Chandran Nadarajan/LinkedIn
Jun 7, 2026, 06:57
Chandran Nadarajan: Targeted Endovascular Thrombolysis Offers Organ-Saving Benefits in Vascular Occlusions
Chandran Nadarajan, Clinical and Interventional Radiologist at Gleneagles Hospital Kota Kinabalu, shared a post on LinkedIn:
“Catheter-Directed Thrombolysis (CDT)
A minimally invasive, image-guided treatment designed to dissolve dangerous blood clots and restore healthy blood flow.
CDT delivers clot-busting medication directly into the clot, helping to:
- Restore circulation quickly
- Preserve limbs and healthy tissue
- Reduce complications
- Minimize damage to surrounding blood vessels
- Shorten hospital stay and recovery time
This treatment may be suitable for conditions such as:
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Acute Limb Ischemia
- Thrombosed Dialysis Access
- May-Thurner Syndrome.”
Stay updated with Hemostasis Today.
-
Sep 11, 2026, 17:01EAHAD 2027 Marks 20 Years
-
Sep 11, 2026, 16:54Denise Braendgaard: Reimagining Health Systems Through Collective Action
-
Sep 11, 2026, 16:47Jehad Khamaysa: Budd-Chiari Syndrome as the Initial Presentation of Behçet’s Disease in a 16-Year-Old
-
Sep 11, 2026, 16:44Mostafa Faisal Mohammed Saleh: From HLA Biology to Curative Therapy
-
Sep 11, 2026, 16:38Jim Kaveney: Class I, Level A – Lifestyle is Now the Official Standard in AFib Care
-
Sep 11, 2026, 16:31George Touma: Do We Really Need to Implant Metal in Every High-Bleeding-Risk Patient?
-
Sep 11, 2026, 16:24Yonah S. Tehrani: CDT vs Anticoagulation in Intermediate High Risk PE – The PRAGUE-26 Trial
-
Sep 11, 2026, 16:09Elad Anter։ A New Map of Atrial Fibrillation Initiation
-
Sep 11, 2026, 15:55Marwa Mostafa: The Paradox of Sideroblastic Anemia